|
시장보고서
상품코드
1959610
모발 성장 보조제 및 치료 시장 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)Hair Growth Supplement and Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
세계의 모발 성장 보조제 및 치료 시장은 2025년에 88억 달러로 평가되었고, 2035년까지 연평균 복합 성장률(CAGR) 6.1%로 성장하여 157억 달러에 이를 것으로 예측됩니다.
원형탈모증, 휴지기 탈모증, 기타 두피 질환 등 모발 질환의 유병률 증가로 인해 시장이 크게 확대되고 있으며, 소비자들은 외모와 자신감을 향상시킬 수 있는 효과적인 해결책을 찾고 있습니다. 탈모 증가, 외모에 대한 인식 증가, 소매점과 온라인 채널에서 임상적으로 입증된 일반의약품과 처방약이 출시되면서 수요가 더욱 증가하고 있습니다. 소비자들은 현재 예방적 모발 관리, 웰빙, 과학적으로 입증된 치료법을 우선시하고 있으며, 그 결과 영양 보충제, 외용제, 비침습적 치료 기기의 채택이 증가하고 있습니다. 인지도, 접근성, 기술 혁신의 결합으로 모발 성장 보조제 및 치료는 현대의 퍼스널케어 및 건강 관리 루틴의 핵심 요소로 자리매김하고 있습니다.
| 시장 범위 | |
|---|---|
| 개시 연도 | 2025년 |
| 예측 기간 | 2026-2035년 |
| 개시 금액 | 88억 달러 |
| 예측 금액 | 157억 달러 |
| CAGR | 6.1% |
이 시장에는 탈모 예방, 발모 촉진, 두피 전체 건강 개선을 목적으로 하는 다양한 제품이 포함됩니다. 여기에는 비타민, 미네랄, 식물 추출물을 포함한 경구용 보충제, 외용제 및 의약품 요법(처방약 및 첨단 비침습적 장치 포함)이 포함됩니다.
제약 부문은 2025년 62억 달러의 매출을 기록할 것으로 예측됩니다. 이는 남성형 탈모증(안드로겐성 탈모증) 및 기타 탈모증에 대한 임상적으로 입증된 치료법에 대한 수요 증가가 주요 요인으로 작용하고 있습니다. 경구약, 외용제, 주사제 및 전문 의료기기는 높은 효과와 환자 치료 결과의 개선으로 계속해서 주목을 받고 있습니다.
남성용 시장은 2035년까지 104억 달러에 달할 것으로 예상되며, 연평균 5.9%의 성장률을 보일 것으로 전망됩니다. 남성 우위는 주로 남성형 탈모증의 높은 유병률에 기인하며, 50세까지 남성의 거의 절반이, 80세까지 대다수의 남성이 발병합니다. 보충제의 편리함과 기술적으로 진보한 외용 치료, 레이저 캡, 두피 자극기 등 비침습적 장치가 결합되어 남성 소비자의 채택을 촉진하고 시장 성장에 크게 기여하고 있습니다.
북미의 탈모증 유병률이 높고 혁신적 치료법이 널리 보급되면서 북미 모발 성장 보조제 및 치료제 시장은 2025년 44.3%의 점유율을 차지하며 선두를 유지할 것으로 예측됩니다. 의약품, 건강기능식품, 비침습적 기기의 발전과 더불어 자연에서 유래하고 임상적으로 입증된 헤어케어 솔루션에 대한 소비자 선호도가 높아지면서 성장세를 더욱 촉진하고 있습니다. 접근하기 쉬운 의료 인프라, 소비자의 인식, 규제적 지원이 결합되어 북미의 우위를 뒷받침하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 업계 인사이트
제4장 경쟁 구도
제5장 시장 추산·예측 : 유형별, 2022-2035년
제6장 시장 추산·예측 : 성별, 2022-2035년
제7장 시장 추산·예측 : 유통 채널별, 2022-2035년
제8장 시장 추산·예측 : 지역별, 2022-2035년
제9장 기업 개요
LSH 26.03.26The Global Hair Growth Supplement and Treatment Market was valued at USD 8.8 billion in 2025 and is estimated to grow at a CAGR of 6.1% to reach USD 15.7 billion by 2035.
The market is witnessing strong expansion due to the rising prevalence of hair disorders such as alopecia areata, telogen effluvium, and other scalp conditions, driving consumers to seek effective solutions that enhance appearance and self-confidence. Increasing hair thinning, growing awareness around personal grooming, and the availability of clinically supported over-the-counter and prescription solutions across both retail and online channels are further fueling demand. Consumers are now prioritizing preventive hair care, wellness, and scientifically validated treatments, which has resulted in rising adoption of dietary supplements, topical solutions, and non-invasive therapeutic devices. The convergence of awareness, accessibility, and technological innovation is positioning hair growth supplements and treatments as a core component of modern personal care and healthcare routines.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $8.8 Billion |
| Forecast Value | $15.7 Billion |
| CAGR | 6.1% |
The market includes a broad range of products designed to prevent hair loss, stimulate regrowth, and improve overall scalp health. This encompasses oral supplements containing vitamins, minerals, and botanical extracts, alongside topical and pharmaceutical therapies, which include prescription medications and advanced non-invasive devices.
The pharmaceuticals segment generated USD 6.2 billion in 2025, driven by the growing demand for clinically proven interventions for androgenetic alopecia and other forms of hair loss. Oral medications, topical solutions, injectables, and specialized devices continue to gain traction due to their high efficacy and improved patient outcomes.
The men segment is expected to reach USD 10.4 billion by 2035, growing at a CAGR of 5.9%. Male dominance is largely attributed to the high prevalence of androgenetic alopecia, with nearly half of men affected by age 50 and a significant majority by age 80. The convenience of supplements, coupled with technologically advanced topical treatments and non-invasive devices such as laser caps and scalp stimulators, has strengthened adoption among male consumers, contributing substantially to market growth.
North America Hair Growth Supplement and Treatment Market accounted for 44.3% share in 2025, maintaining leadership due to the region's high hair loss prevalence and strong adoption of innovative treatments. Growth is further supported by advances in pharmaceuticals, dietary supplements, and non-invasive devices, along with rising consumer preference for natural and clinically validated hair care solutions. The combination of accessible healthcare infrastructure, consumer awareness, and regulatory support underpins North America's dominant position.
Key players in the Global Hair Growth Supplement and Treatment Market include GNC Holdings, Cipla Limited, Amway Corporation, Pfizer, Nature's Bounty, HUM Nutrition, ExoCoBio, Eli Lilly and Company, OUAI Healthcare, Merck, Viviscal Limited (Church & Dwight), Kenvue, Lexington International, Curallux, Keranique, and Nutraceutical Wellness. Companies in this market are employing strategies such as investing heavily in R&D to create clinically validated and multi-functional products, expanding product portfolios to target gender-specific and age-specific needs, and leveraging advanced delivery technologies to improve efficacy. Strategic partnerships with dermatologists, wellness influencers, and online health platforms are used to enhance brand credibility and reach. Firms are also focusing on omnichannel distribution, combining e-commerce, retail, and subscription services to boost accessibility and retention, while emphasizing marketing campaigns centered on scientific validation, natural ingredients, and visible results to strengthen their market foothold and consumer trust.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definition
- 1.2 Research approach
- 1.3 Quality commitments
- 1.3.1 GMI AI policy and data integrity commitment
- 1.3.1.1 Source consistency protocol
- 1.3.1 GMI AI policy and data integrity commitment
- 1.4 Research trail and confidence scoring
- 1.4.1 Research trail components
- 1.4.2 Scoring components
- 1.5 Data collection
- 1.5.1 Partial list of primary sources
- 1.6 Data mining sources
- 1.6.1 Paid sources
- 1.6.1.1 Sources, by region
- 1.6.1 Paid sources
- 1.7 Base estimates and calculations
- 1.7.1 Revenue share analysis
- 1.7.2 Base year calculation
- 1.8 Forecast model
- 1.9 Research transparency addendum
- 1.9.1 Source attribution framework
- 1.9.2 Quality assurance metrics
- 1.9.3 Our commitment to trust
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- 2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Type trends
- 2.2.3 Gender trends
- 2.2.4 Distribution channel trends
- 2.3 CXO perspectives: Strategic imperatives
- 2.3.1 Key decision points for industry executives
- 2.3.2 Critical success factors for market players
- 2.4 Future outlook and strategic recommendations
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing prevalence of hair loss and alopecia
- 3.2.1.2 Rising consumer awareness and self-care trends
- 3.2.1.3 Expansion of e-commerce and direct-to-consumer channels
- 3.2.1.4 Advancements in treatment technologies and clinical research
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Growing availability of alternative treatment options
- 3.2.2.2 Concerns associated with pharmacological treatments
- 3.2.3 Market opportunities
- 3.2.3.1 Rising demand for personalized and precision solutions
- 3.2.3.2 Growth in combination therapies and adjunct solutions
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East and Africa
- 3.5 Pipeline analysis
- 3.6 Pricing analysis
- 3.7 Future market trends
- 3.8 Porter’s analysis
- 3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Key developments
- 4.6.1 Merger and acquisition
- 4.6.2 Partnership and collaboration
- 4.6.3 New product launches
- 4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)
- 5.1 Key trends
- 5.2 Supplements
- 5.2.1 By product type
- 5.2.1.1 Single-ingredient supplements
- 5.2.1.2 Multi-ingredient supplements
- 5.2.2 By dosage form
- 5.2.2.1 Powder
- 5.2.2.2 Gummies
- 5.2.2.3 Tablets
- 5.2.2.4 Capsules
- 5.2.2.5 Liquid
- 5.2.2.6 Other dosage forms
- 5.2.1 By product type
- 5.3 Pharmaceuticals
- 5.3.1 Oral medications
- 5.3.2 Topical and injectables
- 5.3.3 Devices
Chapter 6 Market Estimates and Forecast, By Gender, 2022 - 2035 ($ Mn)
- 6.1 Key trends
- 6.2 Male
- 6.3 Female
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2022 - 2035 ($ Mn)
- 7.1 Key trends
- 7.2 Hospital pharmacies
- 7.3 E-commerce
- 7.3.1 Online retailers
- 7.3.2 Brand-owned websites
- 7.4 Retail pharmacies
- 7.5 Drug stores
- 7.6 Other distribution channels
Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
Chapter 9 Company Profiles
- 9.1 Hair supplements
- 9.1.1 Amway Corporation
- 9.1.2 GNC Holdings
- 9.1.3 HUM Nutrition
- 9.1.4 Nature’s Bounty
- 9.1.5 Nutraceutical Wellness
- 9.1.6 OUAI Healthcare
- 9.1.7 Phyto
- 9.1.8 Viviscal Limited (Church & Dwight)
- 9.2 Hair treatment
- 9.2.1 Cipla
- 9.2.2 Curallux
- 9.2.3 Eli Lilly and Company
- 9.2.4 ExoCoBio
- 9.2.5 Keranique
- 9.2.6 Kenvue
- 9.2.7 Lexington International
- 9.2.8 Merck
- 9.2.9 Pfizer
